Leslie Sam, President, Leslie Sam and Associates, LLC and Lisa Collins, Co-Founder, Head of Clinical Research at Innomas Clinical...

Merck KGaA, a renowned science and technology company, has discontinued its Phase III clinical trials for xevinapant in treating...

Scholar Rock, a biotechnology company, has initiated the Phase 2 EMBRAZE trial to evaluate apitegromab, a myostatin inhibitor, for...

Institute for Systems Biology (ISB) researchers have developed a new method to predict individual-specific short-chain fatty acid (SCFA) production...

According to a recent report, “The State Of Digital Excellence In The Global Pharmaceutical Industry, 2023: Clinical Operations,” by...

Tectonic Therapeutic, Inc. (TECX) has merged with AVROBIO, Inc. and will operate as Tectonic Therapeutic, Inc., trading on Nasdaq...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to ELEVIDYS for ambulatory Duchenne muscular dystrophyDuchenne muscular...

A phase 3 clinical trial known as PURPOSE 1 has yielded breakthrough results in HIV prevention. The trial studied...

CellxLife, a newly established company, aims to revolutionize treatment for children with recurring metastatic Ewing sarcoma and osteosarcoma. The...

Precision BioSciences, a gene editing company, has appointed Dr. Mark Sulkowski and Dr. Jordan Feld to its Hepatitis Scientific...